Immediate Impact
60 standout
Citing Papers
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
2022 Standout
Works of A. Elkind being referenced
Botulinum Toxin Type A in the Prophylactic Treatment of Chronic Tension-Type Headache: A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study
2006
Cutaneous blood flow in vascular headaches of the migraine type
1964
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A. Elkind | 388 | 264 | 41 | 258 | 8 | 457 | |
| Peter J. Goadsby | 382 | 276 | 43 | 235 | 12 | 511 | |
| Andreas Peikert | 343 | 204 | 33 | 184 | 11 | 468 | |
| Aftab Alam | 392 | 223 | 42 | 123 | 11 | 449 | |
| Gordon Mackie | 323 | 169 | 36 | 108 | 12 | 459 | |
| Peter J. McAllister | 360 | 252 | 31 | 189 | 13 | 423 | |
| Jack A. Klapper | 370 | 268 | 12 | 202 | 11 | 501 | |
| WB Young | 321 | 160 | 35 | 171 | 16 | 510 | |
| K. Roger Aoki | 178 | 121 | 42 | 188 | 6 | 375 | |
| Michael L. Hochberg | 318 | 190 | 16 | 117 | 11 | 389 | |
| Rachel Hering‐Hanit | 316 | 167 | 20 | 133 | 19 | 459 |
All Works
Loading papers...